Detalhe da pesquisa
1.
Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells.
Front Immunol
; 14: 1229712, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022506
2.
In silico and in vitro arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patterns.
Front Immunol
; 13: 1035515, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36466864